In relation to "Pharmacological treatment of gestational diabetes mellitus: point/counterpoint" by Oded Langer

Affiliations

¹ Institute of Biomedical Research (IIB Sant Pau) and Department of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; CIBER-BBN (Center of Network Biomedical Investigation - Bioengineering, Biomaterials and Nanotechnology), Instituto de Salud Carlos III, Madrid, Spain; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: rcorcoy@santpau.cat.
² Department of Endocrinology and Nutrition, Hospital Universitari Mútua de Terrassa, Terrassa, Spain.
³ Institute of Biomedical Research (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

Comment

Rosa Corcoy et al. Am J Obstet Gynecol. 2018 Dec.

. 2018 Dec;219(6):629-630.

doi: 10.1016/j.ajog.2018.08.014. Epub 2018 Aug 16.

¹ Institute of Biomedical Research (IIB Sant Pau) and Department of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; CIBER-BBN (Center of Network Biomedical Investigation - Bioengineering, Biomaterials and Nanotechnology), Instituto de Salud Carlos III, Madrid, Spain; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: rcorcoy@santpau.cat.
² Department of Endocrinology and Nutrition, Hospital Universitari Mútua de Terrassa, Terrassa, Spain.
³ Institute of Biomedical Research (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

No abstract available

Comment in

Reply.
Langer O. Langer O. Am J Obstet Gynecol. 2018 Dec;219(6):630. doi: 10.1016/j.ajog.2018.08.013. Epub 2018 Aug 16. Am J Obstet Gynecol. 2018. PMID: 30121227 No abstract available.

Pharmacological treatment of gestational diabetes mellitus: point/counterpoint.
Langer O. Langer O. Am J Obstet Gynecol. 2018 May;218(5):490-499. doi: 10.1016/j.ajog.2018.01.024. Epub 2018 Feb 28. Am J Obstet Gynecol. 2018. PMID: 29499921